First published online 9 April 2008
doi: 10.1242/dev.018853
Development 135, 1791-1801 (2008)
Published by The Company of Biologists 2008
Dkk1 and Wnt3 interact to control head morphogenesis in the mouse
Samara L. Lewis1,
Poh-Lynn Khoo1,
R. Andrea De Young1,
Kirsten Steiner1,
Chris Wilcock2,
Mahua Mukhopadhyay3,
Heiner Westphal3,
Robyn V. Jamieson1,2,
Lorraine Robb4 and
Patrick P. L. Tam1,2,*
1 Embryology Unit, Children's Medical Research Institute, University of Sydney,
Locked Bag 23, Wentworthville, New South Wales, NSW 2145, Australia.
2 Faculty of Medicine, University of Sydney, Locked Bag 23, Wentworthville, New
South Wales, NSW 2145, Australia.
3 Laboratory of Mammalian Genes and Development, National Institute of Child
Health and Human Development, National Institute of Health, Bethesda, MD
20892, USA.
4 The Walter and Eliza Hall Institute of Medical Research, 1G, Royal Parade,
Parkville, Victoria 3050, Australia.

View larger version (65K):
[in this window]
[in a new window]
|
Fig. 1. Enhanced expression of the WNT reporter in the Dkk1-/-
embryo. (A-J) Expression pattern of the BATGal reporter in (A-E)
wild-type and (F-J) Dkk1-/- embryos (A,F, E7.0; B,G, E7.5;
C,H, E7.75; D,I, E8.5; E,J, E9.5). In the mutant embryos, the lacZ
expression domain expands to the anterior germ layer tissues at E7.0-7.75,
encompasses the whole head folds at E8.5 and reaches the rostral-most region
of the truncated head. Scale bar: 50 µm.
|
|

View larger version (84K):
[in this window]
[in a new window]
|
Fig. 2. Impact of loss of Dkk1 on mesoderm and endoderm differentiation and
anterior morphogenesis. (A) Dkk1-/- embryo
shows an expanded domain (black asterisk) of BATGal (2/2 embryos) and
Axin2 expression (3/3 embryos) in the head folds and anterior
tissues, and loses head structures anterior to the upper hindbrain level (red
arrow) with an abrupt truncation of Shh-expressing axial mesoderm and
floor plate. Scale bar: 100 µm. (B,C) Marker analysis of the
wild-type and Dkk1-/- embryos at E7.0 (B: Foxa2, Chrd
and Lhx1; C: Cer1 and Sox17), E7.5 (B: Mixl1,
T and Tbx6), E8.5 (C: Foxa2) and E9.0 (C:
Sox17). Scale bar: 50 µm. Markers of anterior visceral endoderm
are expressed in the mutant embryos (black asterisk). The domain (indicated by
lines) of Foxa2 and Chrd expression in the node area is
broader, and T expression extends more anteriorly in the head process
mesoderm. The endoderm is formed (Cer1), but fewer Sox17-
expressing cells are present in the mutant embryo (black arrow).
Sox17 expression is absent in the foregut of the E9.0 mutant embryo.
At E8.5, the head truncation is clearly visible (Foxa2: whole-mount
embryo, red arrow), and the histology (transverse section of the head) shows
reduced Foxa2 expression in the foregut (red asterisk) and the neural
plate (green bar).
|
|

View larger version (81K):
[in this window]
[in a new window]
|
Fig. 3. Expression of WNT signalling pathway components in the mutant
embryo. (A,B) Double in situ hybridization showing
Dkk1 (orange) and Wnt3 (purple) expression domains. (A) At
E6.5, the Dkk1 expression domain is juxtaposed to the Wnt3
domain. (B) At E7.25, the two domains become wider apart. (C-G')
Wild-type (C-G) and Dkk1-/- (C'-G') E7.0
embryos: the domain of Wnt3 (C,C') remain unchanged, but that
of Wnt2b (D,D'; six out of six mutant embryos) and
Wnt8a (E,E'; one out of three mutant embryos) are slightly
expanded in Dkk1-null embryos. The expression domain of
Sfrp1 (F,F') is reduced while that of Srfp5
(G,G') is unchanged. (H) The domain of Dkk1 expression
becomes more restricted with the decrease in Wnt3 gene dose.
(I) RT-PCR analysis of Dkk1 expression in NIH3T3 cells
expressing lacZ, Wnt1,Wnt3a, Wnt4, Wnt5a, Wnt7a and Wnt11.
-RT, no reverse transcription control; Hprt, loading control.
(J) Reduced domain of Dkk1 expression in the
Dkk1+/-;Wnt3+/- embryo, compared with
Dkk1+/+;Wnt3+/+,
Dkk1+/+;Wnt3+/- and
Dkk1+/-;Wnt3+/+ embryos (top row, lateral view;
bottom row, frontal view). In situ hybridization for H and J was performed
under the same conditions so that the staining result can be compared among
embryos of each set. Scale bar: 50 µm.
|
|

View larger version (56K):
[in this window]
[in a new window]
|
Fig. 4. Anterior defects of the compound
Dkk1+/-;Wnt3+/- mutant embryo. (A)
The E9.5 Dkk1+/-;Wnt3+/- embryos display the
four categories of phenotypes (Class I-IV) with different degrees of head and
trunk defects, compared with single heterozygous
(Dkk1+/-;Wnt3+/+ and
Dkk1+/+;Wnt3+/-) embryo with normal
head morphology and single homozygous mutants showing head truncation
(Dkk1-/-;Wnt3+/+) or arrested development at
gastrulation (Dkk1+/+;Wnt3-/-, broken
white line marks the embryonic/extra-embryonic border of the embryo).
(B) BATgal reporter is expressed ectopically in cells in the anterior
region (red asterisks) of the E7.75 compound
Dkk1+/-;Wnt3+/- mutant embryo. Analysis of
marker expression reveals the loss of forebrain tissue at E8.5 (Fgf8,
Hesx1 and Six3). In the
Dkk1+/-;Wnt3+/- embryos, Fgf8
expression is reduced in the commissural plate (arrow) but not altered in the
isthmus (black asterisk). Tissues anterior to the Hesx1-expressing
domain are reduced (red asterisk). Six3 expression is reduced in the
ventral forebrain (red asterisk). At E9.5, the expression domain of
Nkx2.1, which marks the ventral forebrain is reduced but that of
Pax6 for dorsal forebrain tissues is maintained. Broken line
indicates the length of the forebrain, which is slightly shorter in the mutant
embryo).
|
|

View larger version (50K):
[in this window]
[in a new window]
|
Fig. 5. Partial rescue of the head and forebrain defects in the
Dkk1-/- embryo with reduced Wnt3 gene dose.
(A) Comparison of the morphology of the
Dkk1+/+;Wnt3+/+,
Dkk1-/-;Wnt3+/- and
Dkk1-/-;Wnt3+/+ embryos
showing the almost complete to partial restoration of head structures in the
Dkk1-/-;Wnt3+/- embryo at E9.5 and E10.5.
(B) Marker analysis of wild-type
(Dkk1+/+;Wnt3+/+), `rescued'
(Dkk1-/-;Wnt3+/-) and Dkk-null
(Dkk1-/-;Wnt3+/+) embryos (E8.5: TopGal,
Six3 and Fgf8; E9.5: En1 and Dlx5). The
presence of TOPGal-free and Six3-expressing domains (arrows) show the
restoration of forebrain tissue in the `rescued' embryos. Expression of
Fgf8 is present in the commissural plate (arrow) of the rescued
embryo but is weaker than the wild type, whereas the isthmus is restored to a
normal position (asterisk) that is shifted rostrally in the
Dkk1-/-;Wnt3+/+ embryo. En1 is
restored to nearly wild-type pattern in the midbrain of the rescued embryo
(asterisk). Dlx5 expression (arrows) reveals the improved development
of the branchial arch in the rescued embryo.
|
|

View larger version (58K):
[in this window]
[in a new window]
|
Fig. 6. The scheme of genetic interaction and the requirement of Dkk1
and Wnt3 activity in anterior morphogenesis. (A) The
modulation of WNT3 signalling by the antagonistic action of DKK1 maintains a
correct level of patterning activity. (B) Halving the dose of both
genes in the Dkk1+/-;Wnt3+/- embryo would
theoretically produce a `balanced' level of patterning activity but at a
reduced level (thinner arrow and inhibitory connector). (C) Because of
the requirement of WNT3 signalling to regulate the expression of
Dkk1, the reduced level of signalling associated with the
Wnt3+/- genotype and the loss of one copy of transcription
target Dkk1 gene in the
Dkk1+/-;Wnt3+/- embryo have resulted in a
reduction of DKK1 activity to below the heterozygous
(Dkk1+/-) level, which may be inadequate for antagonizing
WNT3 signalling (dotted inhibitory connector). This may lead to an unbalanced
(and reduced) WNT3 signalling activity (broken arrow) that disrupts head
morphogenesis in the Dkk1+/-;Wnt3+/- embryos.
(D-H) The schematic profile of agonist (WNT3) and antagonist (DKK1)
activity (red, WNT3 signal; green, DKK1 activity; white, no activity; shaded,
reduced activity) in embryos of different Dkk1 and Wnt3
genotypes, correlated with the pattern of WNT reporter (TOPGal) expression in
the E7.75 and E9.5 embryos, and the phenotypic consequences. (D) A balanced
Dkk1 and Wnt3 activity in the wild-type embryo enables
normal pattering and morphogenesis of anterior (head) structures. (E,F) The
unbalanced agonist and antagonist activity leads to an elevated WNT signalling
(revealed by the expanded TOPGal expression domain) and abnormal phenotypic
outcome in embryos of (E) Dkk1-/-;Wnt3+/+
(Dkk1 null) and (F) Dkk1+/-;Wnt3+/-
(compound heterozygous) embryos. (G) In
Dkk1-/-;Wnt3+/- (rescued) embryos, the TOPGal
expression domain is very similar to that of (D) the wild-type embryo. (H)
Wnt3-null embryos do not develop beyond gastrulation and show no
TOPGal expression when examined at E7.75 or E9.0, which may indicate a
complete shutdown of WNT signalling function owing to arrested
development.
|
|

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
© The Company of Biologists Ltd 2008